Nutriband Inc. (NASDAQ:NTRBW) Sees Large Increase in Short Interest

Nutriband Inc. (NASDAQ:NTRBW) was the recipient of a large growth in short interest in August. As of August 31st, there was short interest totaling 1,746 shares, a growth of 9,600.0% from the August 15th total of 18 shares. Based on an average daily volume of 10,970 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Investors Weigh In On Nutriband

An institutional investor recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new stake in shares of Nutriband Inc. (NASDAQ:NTRBW) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband makes up about 0.1% of Empery Asset Management LP’s investment portfolio, making the stock its 20th largest holding.

Nutriband Trading Up 95.0%

NTRBW stock opened at $0.39 on Friday. Nutriband has a 52 week low of $0.17 and a 52 week high of $2.99. The firm has a 50 day moving average of $0.54 and a 200 day moving average of $0.97.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.